Login/Sign Up
₹7790*
MRP ₹9500
18% off
₹8075*
MRP ₹9500
15% CB
₹1425 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Available Offers
Whats That
About Innotubilin 120 Injection 3 ml
Innotubilin 120 Injection 3 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues.
Innotubilin 120 Injection 3 ml contains Docetaxel, which belongs to the anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent, i.e., it prevents the cancer cells from rapidly dividing and spreading.
Innotubilin 120 Injection 3 ml will be administered by a healthcare professional. Your doctor will decide the dosage depending on your medical condition. The common side effects of Innotubilin 120 Injection 3 ml include pain/swelling at the injection site, headache, fatigue, dizziness, drowsiness, constipation, loss of appetite, indigestion, tearing of the eyes, nausea, vomiting, diarrhoea, insomnia (sleeplessness), fever (please inform your doctor if you have fever), muscle aches, and breathlessness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not use or stop this medicine if the doctor did not advise you. Before starting Innotubilin 120 Injection 3 ml, let your doctor know if you have any allergic reactions, medical history of liver or kidney diseases, heart diseases, blood pressure problems, fits, lung disorders, weak immune system, anemia, low white blood cell count, vision problems, and are receiving chemotherapy. Innotubilin 120 Injection 3 ml is not indicated for use in pregnant and breastfeeding women. Innotubilin 120 Injection 3 ml may make you feel dizzy and drowsy, hence do not drive or operate machinery. It is not recommended to consume alcohol along with Innotubilin 120 Injection 3 ml. Innotubilin 120 Injection 3 ml is not recommended for children below two years of age.
Uses of Innotubilin 120 Injection 3 ml
Directions for Use
Medicinal Benefits
Innotubilin 120 Injection 3 ml contains Docetaxel that belongs to the family of anticancer drugs. It works by slowing down cell growth. It is a cytotoxic agent and prevents cancer cells from rapidly dividing and spreading. Docetaxel may be used alone or in combination with other chemotherapy drugs to treat breast cancer that has spread to the tissues and lymph nodes (locally advanced breast cancer) and other parts (secondary breast cancer). It is also used in prostate cancer that does not respond to hormone treatment. It is further being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers.
How Innotubilin 120 Injection 3 ml Works
Storage
Side Effects of Innotubilin 120 Injection 3 ml
What if I have taken an overdose of Innotubilin 120 Injection 3 ml
Drug Warnings
Inform your doctor if you have any allergic reactions to Innotubilin 120 Injection 3 ml or other medications. Before starting Innotubilin 120 Injection 3 ml, let your doctor know if you have any medical history of allergic reactions, non-small cell lung cancer, liver or kidney diseases, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Innotubilin 120 Injection 3 ml can affect the unborn baby when used in pregnancy. It may also have harmful effects on the breastfed infant when used by a lactating mother. Hence, Innotubilin 120 Injection 3 ml is not indicated in pregnancy and breastfeeding women. If you are using Innotubilin 120 Injection 3 ml, use reliable contraception forms to prevent pregnancy during the course. Innotubilin 120 Injection 3 ml can make you feel dizzy and drowsy, thus affecting your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Avoid alcohol consumption while being treated with Innotubilin 120 Injection 3 ml. Innotubilin 120 Injection 3 ml is not recommended for patients younger than 18 years of age.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
by Others
by Others
by Others
by Others
by Others
Product Substitutes
Alcohol
Unsafe
It is unsafe to consume alcohol while using Innotubilin 120 Injection 3 ml since it may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Pregnancy
Unsafe
It is unsafe to use Innotubilin 120 Injection 3 ml in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Innotubilin 120 Injection 3 ml.
Breast Feeding
Unsafe
Innotubilin 120 Injection 3 ml is not recommended during breastfeeding since it may be unsafe for the breastfed infant. Please seek medical advice if you are a nursing mother before starting Innotubilin 120 Injection 3 ml.
Driving
Unsafe
Innotubilin 120 Injection 3 ml causes dizziness and drowsiness that may affect your ability to drive. Do not drive or operate machinery if you experience unmanageable side effects with Innotubilin 120 Injection 3 ml.
Liver
Caution
Please let your doctor know if you have any history of liver diseases or hepatic impairment. Before being treated with Innotubilin 120 Injection 3 ml, your doctor may advise you of blood tests to check your liver functioning.
Kidney
Caution
Please let your doctor know if you have any history of kidney diseases before starting Innotubilin 120 Injection 3 ml.
Children
Unsafe
Safety and efficacy of Innotubilin 120 Injection 3 ml have not been established in patients younger than 18 years.
Innotubilin 120 Injection 3 ml belongs to the class of 'anti-neoplastic/anti-cancer drugs', primarily used as a chemotherapy drug to treat cancers. It is effectively used in breast, lung, prostate, stomach, head/neck cancers.
Innotubilin 120 Injection 3 ml contains Docetaxel, an anti-neoplastic agent. It prevents the cancer cells from rapidly dividing and spreading, thus slowing down their growth.
Innotubilin 120 Injection 3 ml should be used with caution and under doctor's supervision only if you have any medical history of any allergic reactions, liver or kidney diseases, non-small cell lung cancer, heart diseases (congestive heart failure), blood pressure problems, fits, lung disorders (pulmonary effusions (excess fluid around lungs), weak immune system, anemia, low white blood cell count/thrombocytopenia, vision problems, and are already receiving chemotherapy. Let your doctor know if you have any other medical concerns before using Innotubilin 120 Injection 3 ml.
During treatment with Innotubilin 120 Injection 3 ml, it is essential to look for any signs of swelling (fluid retention/oedema), dizziness/fainting, difficulty in breathing, irregular heartbeat, swelling, pain and tenderness in the abdomen region, blood in stools, skin rashes, easy bleeding or bruising, sores in the mouth or throat or symptoms of infection like fever and sore throat. If you further notice any symptoms that are not manageable or unusual, please seek prompt medical attention.
It is advised to consult your doctor before undergoing any vaccination and take advice accordingly. Also, please avoid contact with people who have recently been vaccinated with the oral polio vaccine.
Innotubilin 120 Injection 3 ml might cause serious allergic reactions and fluid retention if you had previously experienced allergic reactions with paclitaxel and cabazitaxel. These medicines contain polysorbate 80, an excipient. If you had any allergic reactions with medicines containing polysorbate 80, Innotubilin 120 Injection 3 ml is not recommended. Please consult your doctor for more information.
Innotubilin 120 Injection 3 ml is administered through an intravenous (IV) infusion. A healthcare professional usually gives it in a medical facility.
Innotubilin 120 Injection 3 ml may cause weight loss due to common side effects such as loss of appetite, nausea, vomiting, diarrhoea, and fatigue. But, in rare cases, some patients may experience fluid retention or increased hunger, which can lead to weight gain. Consult your doctor or pharmacist for personalized guidance if you have concerns about weight changes.
The duration of Innotubilin 120 Injection 3 ml treatment varies depending on the type of your cancer, dose of Innotubilin 120 Injection 3 ml, and your response to therapy. Typically, it is administered once every 3 weeks. Your doctor will determine the total length of treatment for you based on your specific situation.
No, it is advisable not to drink alcohol while taking Innotubilin 120 Injection 3 ml. Drinking alcohol during treatment may cause increased dizziness and drowsiness.
No, Innotubilin 120 Injection 3 ml is not available in pill form. It is available in two primary dosage forms: injection and powder for injection.
Before administering Innotubilin 120 Injection 3 ml, certain blood tests are required to ensure safe administration. These tests include a Complete Blood Count (CBC) to check blood cell counts, blood urea nitrogen (BUN) and creatinine levels to assess kidney function, liver function tests (LFTs) to evaluate liver health, and electrolyte level checks. Additionally, other tests may be required depending on individual patient needs and medical history. These blood tests help healthcare providers assess kidney and liver function and other vital parameters to ensure that Innotubilin 120 Injection 3 ml can be administered safely and effectively. Your healthcare provider will determine the necessary blood tests and monitoring requirements.
Hair loss caused by Innotubilin 120 Injection 3 ml is often reversible. While Innotubilin 120 Injection 3 ml can cause hair thinning or loss, hair growth returns once treatment is stopped. However, in some cases, hair loss may be permanent. Consult your healthcare provider for guidance and support if you're concerned about hair loss.
Dexamethasone is used with Innotubilin 120 Injection 3 ml to avoid toxicities.
Innotubilin 120 Injection 3 ml is a chemotherapy medication that belongs to the class of drugs known as anti-neoplastic/anticancer drugs. It is a cytotoxic agent that prevents the cancer cells from rapidly dividing and spreading.
Innotubilin 120 Injection 3 ml causes dizziness and drowsiness that may affect your ability to drive. So, do not drive or operate machinery if you experience these.
The common side effects of Innotubilin 120 Injection 3 ml may include vomiting, constipation, changes in taste, extreme tiredness, muscle, joint, or bone pain, hair loss, nail changes, increased eye tearing, sores in the mouth and throat, and redness, dryness, or swelling at the injection site. However, these symptoms usually diminish as your body adjusts to the medication. If these symptoms worsen, please consult a doctor for relief.
Innotubilin 120 Injection 3 ml is generally considered safe when following your doctor's advice. However, like all medications, it can have side effects and potential interactions with other drugs. It's important to follow your doctor's instructions and inform them of any pre-existing and existing medical conditions or medication history to avoid negative complications.
Innotubilin 120 Injection 3 ml contains Docetaxel, which belongs to the anticancer drugs.
Safety and efficacy of Innotubilin 120 Injection 3 ml have not been established in patients younger than 18 years.
Country of origin
We provide you with authentic, trustworthy and relevant information